|
|
|
|
Should a Patient Exposed to Shingles Receive the Zoster Vaccine?
_ Should a Patient Exposed to Shingles Receive the Zoster Vaccine?.
|
|
|
Study Finds Association Between Epstein-Barr, Inflammatory Diseases of the Mouth
-- Researchers have found that a significant percentage of dental patients irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.The study was published early online and will appear in the December 2008 issue of...
|
|
|
Association Found between Epstein-Barr Virus and Some Inflammatory Mouth Disease
A significant percentage of dental patients with irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus, according to researchers at Oregon Health & Science University's (OHSU) School of Dentistry.
|
|
|
Epstein-Barr Virus Associated With Inflammatory Diseases Of The Mouth
ScienceDaily (Nov.10, 2008) Researchers at Oregon Health & Science University's School of Dentistry have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical...
|
|
|
Epstein-Barr virus linked to inflammatory diseases of the mouth
Medical Research News Researchers at have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.The Epstein-Barr virus is an...
|
|
|
Understanding Herpes Zoster and the Herpes Zoster Vaccine
_ Understanding Herpes Zoster and the Herpes Zoster Vaccine.
|
|
|
New protease inhibitor doubles treatment response rates in HCV infection
SAN FRANCISCO (Reuters Health) - In patients with treatment-naive chronic hepatitis C virus (HCV) genotype 1 infection, the investigational protease inhibitor boceprevir (Schering-Plough) produces sustained viral response rates that are...
|
|
|
Herpes Zoster with Skin Lesions and Meningitis Caused by 2 Different Genotypes of the Oka Varicella-Zoster Vir
Levin MJ et al.- The vaccine strain from cerebrospinal fluid also contained mutations never previously observed at vaccine-associated single nucleotide polymorphisms that would alter amino acid sequences in ORF54 and ORF59. The presence...
|
|
|
When Blepharoconjunctivitis Refuses to Go Away
When patients present with chronic blepharoconjunctivitis, the condition can cause an unexpected sequela: a headache for the ophthalmologist.The physician has to analyze the various signs, symptoms and differential diagnoses to get to the...
|
|
|
New lung transplantation research presented at CHEST 2008
IRREGULAR HEARTBEAT MAY DEVELOP AFTER LUNG TRANSPLANTATION (Tuesday, October 28, 10:30 AM EST) Patients receiving donated lungs may develop arrhythmias, including atrial fibrillation.Researchers from Baylor College of Medicine in Texas...
|
|
|
Complete Ophthalmoplegia With Pupillary Involvement as an Initial Clinical Presentation of Herpes Zoster Ophth
DeLengocky T et al.- The present report describes a 45-year-old African American woman with human immunodeficiency virus who presented with complaint of new-onset nonspecific headache, acute onset of complete oculomotor nerve palsy, and a...
|
|
|
Vaccine for shingles in short supply
THE COLUMBUS DISPATCH Shingles is awful.Ask anyone who has had the painful disease, which is caused by the same virus that causes chicken pox and usually appears in adults who were infected as children. Good news came two years...
|
|
|
An Industry Analysis of the Anti-Infectives Market Outlook to 2013: Examine the Competitive Landscape, a Pipel
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a7d0e3/the_antiinfective) has announced the addition of the 'The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline...
|
|
|
Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial
/PRNewswire/ -- Epiphany Biosciences, Inc.today announced that a Phase 2b dose-ranging study to evaluate the safety, efficacy, and tolerability of the company's lead compound, valomaciclovir (EPB-348) in patients with acute herpes ...
|
